Two Vaccine Targets on Virus May Be Better Than One

An experimental vaccine developed by GeoVax Labs succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study.
Reuters Health Information

source https://www.medscape.com/viewarticle/970179?src=rss

Comments

Popular posts from this blog

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

New AAFP practice guideline sets blood pressure targets for adults with hypertension